Skip to main content
letter
. 2024 Nov 7;104:42227. doi: 10.2340/actadv.v104.42227

Table I.

Attributes of 45 patients with cutaneous angiosarcoma of the head and neck: comparison between the low-MPV/PC group (< 0.06) and the high-MPV/PC group (≥ 0.06)

Attribute Patient group (%)
p-value*
Patients group (%) Low MPV/PC (MPV/PC < 0.06) High MPV/PC (MPV/PC ≥ 0.06)
Patients (%) 45 (100%) 36 (80) 9 (20)
Age 0.898
 Median [IQR] 76 [68–81] 76 [66.8–81] 76 [72–79]
 Min–max 53–86 53–86 62–84
Sex 1.00
 Male 33 (73.3) 26 (72.2) 7 (77.8)
 Female 12 (26.7) 10 (27.8) 2 (22.2)
ECOG-PS score 1.00
 0–1 41 (91.1) 33 (91.7) 8 (88.9)
 2–4 4 (8.9) 3 (8.3) 1 (11.1)
Primary site 1.00
 Head 43 (95.6) 34 (93.8) 9 (100)
 Face 2 (4.4) 2 (6.3) 0 (0)
Tumour size 0.482
 < 5cm 25 (55.6) 21 (58.3) 4 (44.4)
 ≥ 5cm 20 (44.4) 15 (41.7) 5 (55.6)
Number of skin lesions 0.712
 Single 19 (42.2) 16 (44.4) 3 (33.3)
 Multiple 26 (57.8) 20 (55.6) 6 (66.7)
Lymph node metastasis 0.173
 Absent 41 (91.1) 34 (93.8) 7 (77.8)
 Present 4 (8.9) 2 (6.3) 2 (22.2)
Distant metastasis 0.173
 Absent 41 (91.1) 34 (93.8) 7 (77.8)
 Present 4 (8.9) 2 (6.3) 2 (22.2)
1st line chemotherapy 1.00
 Paclitaxel 32 (71.1) 25 (69.4) 7 (77.8)
 Docetaxel 2 (4.4) 2 (5.6) 0 (0)
 Interleukin-2 11 (24.4) 9 (2.5) 2 (22.2)
Surgery for ASHN 0.086
 Absent 33 (73.3) 24 (66.7) 9 (100)
 Present 12 (26.7) 12 (33.3) 0 (0)
Radiation for ASHN 1.00
 Absent 12 (26.7) 10 (27.8) 2 (22.2)
 Present 33 (73.3) 26 (72.2) 7 (77.8)
Outcome 1.00
 Alive 21 (46.7) 17 (47.2) 4 (44.4)
 Dead 24 (53.3) 19 (52.8) 5 (55.6)

ASHN: angiosarcoma of the head and neck; ECOG-PS: Eastern Cooperative Oncology Group performance; IQR: interquartile range; MPV: mean platelet volume; PC: platelet count.

*

Statistically significant: p < 0.05.